Celldex Therapeutics (CLDX) Earnings Analysis
Celldex Therapeutics (CLDX) next reports earnings on 2026-08-06, consensus EPS -1.04 USD. Last quarter (2026-05-07) it missed with EPS -1.18 USD vs -1.1472 USD est (-2.9%). It has beaten estimates in 3/7 recent quarters (43%). Trailing P/E -8.14.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does CLDX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | -1.04 USD |
| Revenue estimate | 0.00B |
CLDX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | -1.18 USD | -1.1472 USD | -2.9% | Miss |
| 2026-02-25 | -1.22 USD | -1 USD | -22% | Miss |
| 2025-11-10 | -1.01 USD | -0.88 USD | -14.8% | Miss |
| 2025-08-07 | -0.85 USD | -0.86 USD | +1.2% | Beat |
| 2025-05-08 | -0.81 USD | -0.75 USD | -8% | Miss |
| 2025-02-27 | -0.71 USD | -0.73 USD | +2.7% | Beat |
| 2024-08-08 | -0.54 USD | -0.59 USD | +8.5% | Beat |
Beat rate: 3/7 (43%) over reported quarters with consensus data.
CLDX valuation and analyst view
| Trailing P/E | -8.14 |
|---|---|
| Trailing EPS | -4.26177 USD |
| Price / book | 5.07 |
| Dividend yield | 0.00% |
| Market cap | 2.26B |
| Analyst consensus | Buy (16 buy / 3 hold / 0 sell) |
| Avg price target | 58.44 USD |
Related research pages
Frequently asked questions
When is Celldex Therapeutics (CLDX)'s next earnings date?
Celldex Therapeutics is next scheduled to report on 2026-08-06, with a consensus EPS estimate of -1.04 USD and revenue estimate of 0.00B.
Did CLDX beat earnings last quarter?
In its 2026-05-07 report, CLDX posted EPS of -1.18 USD versus a -1.1472 USD estimate — a miss of 2.9%.
What is CLDX's earnings track record?
Over the last 7 reported quarters with consensus data, CLDX beat estimates 3 times (43%).
What is CLDX's current P/E ratio and EPS?
CLDX trades at a trailing P/E of -8.14 on trailing EPS of -4.2617702731124 USD.
What do analysts rate CLDX?
Analyst consensus is "Buy" across 19 ratings (0 strong buy, 16 buy, 3 hold, 0 sell, 0 strong sell). Average 12-month price target: 58.44 USD.